Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CBSC Things should get interesting here pretty soon.
$CBSC Big things imminent here folks. Get ready.
$CBSC @cbscientificinc is SUPER thin!! Better get your shares before it runs to $3+++
JMO—This play needs company updates and reality based shareholder respect via updates to remove the lingering stench of talari and his crew.
Until that time the same old same old downward spiral will continue as expected and called
GL!
$CBSC HOLD AND BUY MORE ON THESE AMAZING DIPS THEY ARE GIFTS.
My pleasure and thank you for the warm welcome
This clarifies everything:
https://backend.otcmarkets.com/otcapi/company/financial-report/249298/content?fbclid=IwAR16v0GhJbJBS6nvKjwgOUbQwleh2l0OxyjB5_1B_VNsvAPKG8WaLbDpGys
I feel confident and it is Time to buy some more shares.
otcrx3 - thanks for the update
Thanks for the information o3.
I’ll remove the sticky and replace it with your post.
Will take a closer look tonight.
Good to see that Verghese is gone as well.
GL
Thank you for the correction - good to see some trades coming in as this may be an interesting investment
TALARI SHARES RETIRED!!! Also New Management/New Company (SEE LINK)
OTC Backend Filings
To Correct the MISINFORMATION posted here about Talari please see
Change In Control And Changes in Management and Directors
TALARI SHARES RETIRED BACK TO TREASURY!!!!
$CBSC CB Scientific plans to make further announcements to keep its shareholders, industry participants, and the public markets informed through press releases and regulatory filings as new developments occur.
$CBSC Going super green and breakout imminent
CBSC cb scientific inc Price $1.27 Float 2,761,062
Outstanding Shares 79,821,106
WEBSITE
CBSC publicly-traded co. on the OTC Pinks providing innovative products & services in the ambulatory non-invasive cardiac monitoring space.
MY-CAM Auto-Trigger Loop Event Recorder
Our innovative my Cam ECG recorder is extremely small & convenient for patients to wear and use.
CBSC CB Scientific Diagnostic Electrocardiograph MarketForcast are expected to reach #US $14.9 #billion by 2030, Globally
#MYCARDIA Cloud-Based Web Portal provides a 24x7 monitoring service featuring innovative devices & software 2 simplify a 30-day event
CBSC Another one of those hidden gems that are in a ginormous market. The Global Diagnostic Electrocardiograph (ECG) Market is expected to exceed more than US$ 6.0 Billion by 2024 at a #CAGR of 5.5% in the given forecast period.
CBSC cb scientific inc I bet is super excited to see this news!!! Hillrom will buy Bardy Diagnostics, a startup that makes a wearable #ECG #patch, for $375 #million in cash. If that was offered to #CBSC it would mean roughly 5.00 per share.
https://medcitynews.com/2021/01/hillrom-to-buy-cardiac-monitoring-company-bardy-diagnostics-for-375m/
$CBSC Take advantage of this buying opportunity @1.27
CBSC—Just another talari scam.
TRADE ACCORDINGLY—GLTA!
AN EXCELLENT SUMMARY OF HOW ALL talari/cox SCHEMES WORK
The following is from a past friend of talari/cox and was a close insider (BOD member) that worked closely with them and knows the facts well;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144462521
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159042006
GLTA!
$CBSC..Keeps moving up-ZERO selling!
$CBSC CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021
Press Release | 12/28/2020
ESCONDIDO, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, announces today the addition of dozens of new device clinical trials of its my-Cam device and new hospital monitoring contracts through the Company’s exclusive authorized distributor, Mango Wellness Co., Ltd. (MWC) and My Cardia Thailand Co., Ltd. (MCT) in Thailand.
Mango Wellness Co., Ltd.’s successful participation as an exhibitor at the Royal College of Physicians of Thailand Annual Conference in Pattaya, Thailand, Oct. 29-31, and again at the Thailand Cardiologist Annual Conference in Hua Hin, Thailand, Dec. 10-12, produced overwhelming interest from more than 160 physicians who have requested on-site evaluations of the Company’s innovative my-Cam monitor and my-Cardia software portal in these two regions of Thailand. Mango Wellness Co., Ltd. and My Cardia Thailand anticipate adding 100 contracted hospitals in the first quarter of 2021, totaling more than 1,000 ambulatory remote cardiac event monitoring tests during this time.
Further penetration of the remote cardiac monitoring market in 1,300 hospitals in Thailand, given the increased shift towards home healthcare and growing concerns pertaining to the early detection of cardiac heart rhythm abnormalities, is expected as MWC and MCT expand their outreach throughout the country.
CB Scientific plans to make further announcements to keep its shareholders, industry participants, and the public markets informed through press releases and regulatory filings as new developments occur.
CB Scientific Inc. Company Contact Information:
340 State Place
Escondido, CA 92029
Telephone number:
(888) 225-0870
Emails:
General inquires: info@cbscientificinc.com
Investor Inquiries: investor@cbscientificinc.com
Company Website and Social Media Outlets:
CB Scientific website, Twitter, Facebook, Instagram and LinkedIn
Mango Wellness Co., Ltd./My Cardia Thailand Co., Ltd. Company Contact Information:
Mango Wellness Co., Ltd.
Glas Haus Building, Level P, Unit PO1
1 Sukhumvit 25, North Klongtoey
Wattana, Bangkok, Thailand 10110
My Cardia Thailand Co., Ltd.
190 Sutthisan Road, Intersection 1
Ratchadaphisek, Dindaeng
Bangkok, Thailand 10400
Telephone number:
+66 (0) 21015576 – Mango Wellness
+66 (0) 971566481 – My Cardia Thailand
Emails:
General inquires: info@mangowellnessthailand.com
info@mycardiathailand.com
Company Website and Social Media Outlets:
www.mangowellnessthailand.com, www.mycardiathailand.com
Twitter - https://twitter.com/ThailandMango
Facebook - https://www.facebook.com/mangowellnessthailand/, https://www.facebook.com/mycardiathailand/
Instagram - https://www.instagram.com/mangowellnessthailand11
You Tube: https://www.youtube.com/channel/UCUkd57GAqiAbwzmHC6wG6OQ, https://www.youtube.com/channel/UCnvz5qPLQjxko1Hc3bUJBDw
Forward-Looking Statements
This information disclosure may contain forward-looking statements covered within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com
cbsc—Father Time certified scam!
Doesn’t mean that money can’t be made
$CBSC..I'm looking for a big week!
CBSC..ZERO selling..Easy $3.with volume!
$CBSC..Wonder if we will be hearing anything about this one before the year is over?>>>>> CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
Press Release | 11/12/2020
ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, is pleased to announce a definitive purchase agreement to acquire Datrix, LLC (Datrix), a global ambulatory device manufacturer based in Escondido, California. Datrix brings to CBSC a diversely experienced team of highly qualified individuals with extensive knowledge of design and engineering related to medical devices utilized in this ever-expanding market. This acquisition further strengthens CBSC’s digital offering with the addition of an existing commercially available product line, which includes wireless mobile cardiac telemetry, cardiac event, extended and standard holter monitoring through the Datrix Sirona and VX3 devices.
Under the terms of the acquisition agreement, Datrix will continue to operate as an OEM manufacturer to its existing customer base and also become the exclusive manufacturer for the next generation of CBSC’s proprietary FDA- and CE-cleared ECG my-Cam Cardiac Event Monitor, including the interactive cloud-based My-Cardia acquisition software and the associated smartphone apps. This acquisition also provides CBSC and its subsidiary My-Cardia (USA) Inc. the opportunity to expand their product offerings quickly with the addition, integration and implementation of Datrix’s wireless Sirona and VX3 devices. The addition of these new products to CBSC’s existing portfolio will now give the Company’s customers several new alternative monitoring/testing choices, which will further help improve earlier remote detection and diagnosis of problematic cardiac rhythms in patients.
Jon Barron, president and founder of Datrix, LLC, said, "We are enthusiastic about our exciting new partnership with CBSC. They provide a great new platform for us to extend the outreach of our current products, improve and enhance their existing offerings, and expand the design and development of newer device technologies, leading to new avenues for improving the detection of cardiac heart rhythm abnormalities remotely."
"We are extremely excited about our acquisition of Datrix, LLC and how it enhances and strengthens the growth trajectory of our business,” said Charles Martin, CBSC CEO. “The acquisition, combined with other expansion efforts already underway, will position CBSC to play a significant role in delivering innovative diagnostic devices and testing into this ever-expanding market, further helping our company to establish a solid footprint in the worldwide remote cardiac ambulatory noninvasive ECG monitoring market."
The acquisition is expected to close during Q4 of fiscal year 2020, subject to customary closing conditions. Financial terms of the agreement are not being disclosed.
As new developments occur, CB Scientific plans to make further announcements through press releases and regulatory filings to keep its shareholders, industry participants and the public markets informed.
About Datrix, LLC:
Datrix, LLC is a leading global manufacturer and provider of ambulatory ECG devices, established in 1988. For over 30 years, medical companies, distributors and dealers have partnered with Datrix to design and develop dependable products with the latest technologies and advancements that meet the highest industry standard. Datrix’s approach to quality exceeds today’s requirements through the implementation of lean manufacturing practices. Their Quality Management System is certified to international standards of ISO 13485 and is in compliance with the Quality Systems Regulations of the FDA, with proprietary devices also bearing CE marking for conformity for marketing in the European Union. The manufacturing facility is registered with the FDA. For more information, please visit: www.datrixmed.com.
CB Scientific Inc. Company Contact Information:
340 State Place
Escondido, CA 92029
Telephone number:
(888) 225-0870
Emails:
General inquires: info@cbscientificinc.com
Investor Inquiries: investor@cbscientificinc.com
Company Website and Social Media Outlets:
CB Scientific website, Twitter, Facebook, Instagram and LinkedIn
This information disclosure may contain forward-looking statements covered within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com
Reality bites;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147286995
JMO—More Pinkyland pump required
$CBSC..A run is coming here just like the rest..
$CBSC..Sweet day..A bit more volume and we hit $2. easy!
While the S/S is attractive—
This scam is for well seasoned traders only.
Longs always get decimated in talari scams.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160270910
Please;
Cbsc..Light volume so far but still feeling kaboom coming..
$CBSC>>>>>The O/S is showing about a million more since the June quarter=very little dilution!>>>>>>return to the Company’s treasury and cancellation of 49,895,801 shares of common stock which he previously acquired from Sam Talari and another minority shareholder. As a result, after the end of June 30, 2020 quarter, and as of the date of this filing, the Company had 78,498,356 shares of common stock outstanding.
$CBSC..LESS than 3 million shares in the float-This can move fast!
$CBSC..Ticking time bomb here..BOO, and it will move!
$CBSC..Zero sellers-Ready to run!
OTC MARKETS SHELL RISK DESIGNATION;
The Shell Risk designation indicates that a company displays characteristics common to Shell Companies. This designation is made at OTC Markets’ sole and absolute discretion based on an analysis of the company’s annual financial data and may differ from issuers’ self-reported shell classifications in their own public filings. Our analysis evaluates asset composition, operational expenditures, and income related metrics. No action is required by a company to perform the evaluation other than publishing current annual financial information.
In limited circumstances, OTC Markets will consider removal of a company’s shell risk designation upon written request by a company. Please be advised that such requests will only be considered when there has been a material change in financial condition since the most recent fiscal year-end that is reflected in publicly available interim financial statements. Examples include a material increase in asset composition or operating revenues with related financial disclosure as a result of an acquisition or change in control transaction.
https://www.otcmarkets.com/glossary#shell-risk
NOTHING HERE BUT INSIDER SHARES TO DUMP
https://investorshub.advfn.com/uimage/uploads/2017/9/30/dcemgBrain_Dump_PR.jpg
Take a close look into IFXY—FWDG—NUVG—FUTL.
There are many more talari tickers that have just disappeared into Pinkyland oblivion along with all investors money and were never to be seen again.
Last year another ONE BILLION SHARES were registered TO DUMP
https://ih.advfn.com/stock-market/USOTC/cb-scientific-inc-CBSC/stock-news/79400652/registration-a-offering-under-the-securities-act-o
SAME OLD—SAME OLD
AN EXCELLENT SUMMARY OF HOW ALL talari/cox SCHEMES WORK
The following is from a past friend of talari/cox and was a close insider (BOD member) that worked closely with them and knows the facts well;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144462521
GLTA
$CBSC..I'm feeling a nice price spike coming..
$CBSC..Im gonna stick a toe in tomorrow and touch that bottom..
$CBSC..Bottom in here? Looks ready to go up..
CBSC now pink current
https://www.otcmarkets.com/stock/CBSC
$CBSC CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
Press Release | 11/12/2020
ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire - CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, is pleased to announce a definitive purchase agreement to acquire Datrix, LLC (Datrix), a global ambulatory device manufacturer based in Escondido, California. Datrix brings to CBSC a diversely experienced team of highly qualified individuals with extensive knowledge of design and engineering related to medical devices utilized in this ever-expanding market. This acquisition further strengthens CBSC’s digital offering with the addition of an existing commercially available product line, which includes wireless mobile cardiac telemetry, cardiac event, extended and standard holter monitoring through the Datrix Sirona and VX3 devices.
Under the terms of the acquisition agreement, Datrix will continue to operate as an OEM manufacturer to its existing customer base and also become the exclusive manufacturer for the next generation of CBSC’s proprietary FDA- and CE-cleared ECG my-Cam Cardiac Event Monitor, including the interactive cloud-based My-Cardia acquisition software and the associated smartphone apps. This acquisition also provides CBSC and its subsidiary My-Cardia (USA) Inc. the opportunity to expand their product offerings quickly with the addition, integration and implementation of Datrix’s wireless Sirona and VX3 devices. The addition of these new products to CBSC’s existing portfolio will now give the Company’s customers several new alternative monitoring/testing choices, which will further help improve earlier remote detection and diagnosis of problematic cardiac rhythms in patients.
Jon Barron, president and founder of Datrix, LLC, said, "We are enthusiastic about our exciting new partnership with CBSC. They provide a great new platform for us to extend the outreach of our current products, improve and enhance their existing offerings, and expand the design and development of newer device technologies, leading to new avenues for improving the detection of cardiac heart rhythm abnormalities remotely."
"We are extremely excited about our acquisition of Datrix, LLC and how it enhances and strengthens the growth trajectory of our business,” said Charles Martin, CBSC CEO. “The acquisition, combined with other expansion efforts already underway, will position CBSC to play a significant role in delivering innovative diagnostic devices and testing into this ever-expanding market, further helping our company to establish a solid footprint in the worldwide remote cardiac ambulatory noninvasive ECG monitoring market."
The acquisition is expected to close during Q4 of fiscal year 2020, subject to customary closing conditions. Financial terms of the agreement are not being disclosed.
As new developments occur, CB Scientific plans to make further announcements through press releases and regulatory filings to keep its shareholders, industry participants and the public markets informed.
About Datrix, LLC:
Datrix, LLC is a leading global manufacturer and provider of ambulatory ECG devices, established in 1988. For over 30 years, medical companies, distributors and dealers have partnered with Datrix to design and develop dependable products with the latest technologies and advancements that meet the highest industry standard. Datrix’s approach to quality exceeds today’s requirements through the implementation of lean manufacturing practices. Their Quality Management System is certified to international standards of ISO 13485 and is in compliance with the Quality Systems Regulations of the FDA, with proprietary devices also bearing CE marking for conformity for marketing in the European Union. The manufacturing facility is registered with the FDA. For more information, please visit: www.datrixmed.com.
CB Scientific Inc. Company Contact Information:
340 State Place
Escondido, CA 92029
Telephone number:
(888) 225-0870
Emails:
General inquires: info@cbscientificinc.com
Investor Inquiries: investor@cbscientificinc.com
Company Website and Social Media Outlets:
CB Scientific website, Twitter, Facebook, Instagram and LinkedIn
This information disclosure may contain forward-looking statements covered within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com
CBSC IS A talari INSIDER ENRICHING SCAM AT BEST!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146151911
BUYERS BEWARE!
SUB PENNY IS THE FUTURE HERE—GLTA!
Followers
|
13
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
579
|
Created
|
01/18/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |